Emerging building blocks for medicinal chemistry: recent synthetic advances

OO Grygorenko, DM Volochnyuk… - European Journal of …, 2021 - Wiley Online Library
Current medicinal chemistry relies heavily on the quality of building blocks, ie reagents used
to introduce chemical diversity into the target molecules. The last decade witnessed an …

Design of next-generation covalent inhibitors: Targeting residues beyond cysteine

LH Jones - Annual Reports in Medicinal Chemistry, 2021 - Elsevier
Covalent protein inhibitors have found considerable utility in medicinal chemistry and
chemical biology. Chemical probes and drugs have been rationally designed and fine-tuned …

Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS

T Yamauchi, T Masuda, MC Canver, M Seiler, Y Semba… - Cancer cell, 2018 - cell.com
To identify novel targets for acute myeloid leukemia (AML) therapy, we performed genome-
wide CRISPR-Cas9 screening using AML cell lines, followed by a second screen in vivo …

PF-06651600, a dual JAK3/TEC family kinase inhibitor

H Xu, MI Jesson, UI Seneviratne, TH Lin… - ACS chemical …, 2019 - ACS Publications
PF-06651600 was developed as an irreversible inhibitor of JAK3 with selectivity over the
other three JAK isoforms. A high level of selectivity toward JAK3 is achieved by the covalent …

Covalent enzyme inhibition through fluorosulfate modification of a noncatalytic serine residue

OO Fadeyi, LR Hoth, C Choi, X Feng… - ACS Chemical …, 2017 - ACS Publications
Irreversible enzyme inhibitors and covalent chemical biology probes often utilize the
reaction of a protein cysteine residue with an appropriately positioned electrophile (eg …

Docking study and antiosteoporosis effects of a dibenzylbutane lignan isolated from Litsea cubeba targeting Cathepsin K and MEK1

W Peng, H Shen, B Lin, P Han, C Li, Q Zhang… - Medicinal Chemistry …, 2018 - Springer
Abstract Litsea cubeba (Lour.) Pers.(Lauraceae family) has been used as a folk prescription
in China for the treatment of rheumatic diseases for a long time. Previous studies of our …

Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss

SJ Bouley, AV Grassetti, RJ Allaway… - Journal of Cell …, 2024 - journals.biologists.com
Neurofibromatosis type 1, a genetic disorder caused by pathogenic germline variations in
NF1, predisposes individuals to the development of tumors, including cutaneous and …

Targeting leukemia-specific dependence on the de novo purine synthesis pathway

T Yamauchi, K Miyawaki, Y Semba, M Takahashi… - Leukemia, 2022 - nature.com
Acute myeloid leukemia (AML) is a devastating disease, and clinical outcomes are still far
from satisfactory. Here, to identify novel targets for AML therapy, we performed a genome …

Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells

J Wang, J Wu, X Li, H Liu, J Qin, Z Bai, B Chi… - Journal of …, 2018 - Elsevier
Identification of the specific protein target (s) of a drug is a critical step in unraveling its
mechanisms of action (MOA) in many natural products. Curcumol, isolated from well known …

[HTML][HTML] Ferroptosis induced by DCPS depletion diminishes hepatic metastasis in uveal melanoma

B Jin, L Yang, Q Ye, J Pan - Biochemical Pharmacology, 2023 - Elsevier
Hepatic metastasis develops in∼ 50% of uveal melanoma (UM) patients with scarcely
effective treatment resulting in lethality. The underlying mechanism of liver metastasis …